Scoop: Alto Pharmacy raises $120 million in new funding

• The company was reportedly valued at over $1 billion when it raised $250 million in a round led by SoftBank in 2020. It’s unclear what valuation it had when it raised again in January 2022.
• Talks toward a merger with a special purpose acquisition company that would have taken the company public in 2021 fell apart, per Reuters.

Flashback: CEO Alicia Boler-Davis revealed this past May during Axios’ BFD event in San Francisco that the company was already in talks to raise new funding.

• She also noted the company is on the lookout for more acquisitions, following its purchase of NowRx last year.